New Investigation of Ventrus Biosciences, Inc. (NASDAQ: VTUS)

Haeggquist & Eck, LLP has commenced an investigation into Ventrus Biosciences, Inc. (“Ventrus”), to determine whether it has violated securities laws by issuing false and misleading statements to its shareholders.

Ventrus is a specialty pharmaceutical company that focuses on the development of prescription drugs for gastrointestinal disorders.  On June 25, 2012, Ventrus announced the results of its Phase 3 placebo-controlled trial of its experimental drug iferanserin, also known as VEN 309.  The trial results showed that VEN 309 failed to demonstrate an improvement in therapy in patients with hemorrhoidal disease, and Ventrus announced that had no immediate plans to continue the development of VEN 309.

Upon this announcement, the price of Ventrus stock declined from as high as $12.26 per share on June 22, 2012, to as low as $4.27 on June 29, 2012, and continued to decline to as low as $2.06 per share on November 13, 2012.

Our investigation focuses on whether statements made by Ventrus to the investing public regarding the effectiveness and commercial prospects for VEN 309 were materially false and misleading at the time they were made.

If you are a Ventrus Biosciences, Inc. shareholder who purchased Ventrus common stock between December 17, 2010, and June 22, 2012, you may have claims under the securities laws.  If you wish to discuss this investigation or have questions about this notice or your legal rights, please contact attorney Amber L. Eck at (619) 342-8000.

To schedule your free initial consultation, contact us online or call (619) 342-8000 today!

SHARE

COMMENTS & DISCUSSIONS

Related Posts

Haeggquist & Eck Attorneys posing for picture

California Law Firm, Haeggquist & Eck, Work to Help Women in the Workplace Against Sexual Harassment

In this article by Law360, an all-too-common story is told about how women’s experiences are typically glossed over in the …

Read More
SDSU

Haeggquist & Eck’s Attorney Jenna Rangel and Survivor Advocate Christy Heiskala are featured in KPBS News Story

Haeggquist & Eck’s Attorney Jenna Rangel and Survivor Advocate Christy Heiskala are featured in KPBS news story regarding how outside …

Read More
In the News Banner

Haeggquist & Eck Represents Detectives in Sexual Harassment Suit Against San Diego County Sherriff’s Department

Haeggquist & Eck Partner, Jenna Rangel, is proudly representing two former San Diego Sherriff’s Department detectives in a Sexual Harassment …

Read More
Translate »